Citations (46)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
M. H. M. G. Houben, D. van de Beek, E. F. Hensen, A. J. M. de Craen, B. W. M. van't Hoff, G. N. J. Tytgat. (1999) Helicobacter pylori Eradication Therapy in The Netherlands. Scandinavian Journal of Gastroenterology 34:230, pages 17-22.
Read now
Read now
W. Baffone, F. Belbusti, E. Barbieri, A. Pianetti, F. Bruscolini, M.T. Fabi, L. Salvaggio & A. Albano. (1997) Comparison of Colloidal Bismuth Subcitrate and Metronidazole, Both in Combination with an H2-Antagonist as Therapy for Helicobacter pylori
. Journal of Chemotherapy 9:3, pages 208-212.
Read now
Read now
Harry Hua-Xiang Xia & Nicholas J Talleyd. (1996) Leading Article: Leading Article Anti-infectives: Prospects for improved therapy for Helicobacter pylori infection. Expert Opinion on Investigational Drugs 5:8, pages 959-976.
Read now
Read now
W. A. De Boer & G. N. J. Tytgat. (1995) Review: The Best Therapy for Helicobacter pylori Infection: Should Efficacy or Side-Effect Profile Determine Our Choice?. Scandinavian Journal of Gastroenterology 30:5, pages 401-407.
Read now
Read now
M. G. Korman & G. N. J. Tytgat. (1995) Helicobacter pylori and Peptic Ulcer. Scandinavian Journal of Gastroenterology 30:sup210, pages 92-96.
Read now
Read now
Articles from other publishers (41)
Yunzhi Zou, Xing Qian, Xiaoqun Liu, YanPing Song, Conghua Song, Shuang Wu, Ying An, Rui Yuan, Youhua Wang & Yong Xie. (2020)
The effect of antibiotic resistance on
Helicobacter pylori
eradication efficacy: A systematic review and meta‐analysis
. Helicobacter 25:4.
Crossref
Crossref
L. FISCHBACH & E. L. EVANS. (2007) Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori. Alimentary Pharmacology & Therapeutics 26:3, pages 343-357.
Crossref
Crossref
Brennan M. R. Spiegel, Chiun-Fang Chiou & Joshua J. Ofman. (2005) Minimizing complications from nonsteroidal antiinflammatory drugs: Cost-effectiveness of competing strategies in varying risk groups. Arthritis & Rheumatism 53:2, pages 185-197.
Crossref
Crossref
Wieslaw J. Bochenek, Suzanne Peters, Polly D. Fraga, Wenjin Wang, Michael E. Mack, Michael S. Osato, Hala M. T. El-Zimaity, Kelly D. Davis & David Y. Graham. (2003) Eradication of Helicobacter pylori by 7-Day Triple-Therapy Regimens Combining Pantoprazole with Clarithromycin, Metronidazole, or Amoxicillin in Patients with Peptic Ulcer Disease: Results of Two Double-Blind, Randomized Studies. Helicobacter 8:6, pages 626-642.
Crossref
Crossref
N L A Arents, J C Thijs & J H Kleibeuker. (2002) A rational approach to uninvestigated dyspepsia in primary care: review of the literature. Postgraduate Medical Journal 78:926, pages 707-716.
Crossref
Crossref
Brennan M.R. Spiegel, Nimish B. Vakil & Joshua J. Ofman. (2002) Dyspepsia management in primary care: A decision analysis of competing strategies. Gastroenterology 122:5, pages 1270-1285.
Crossref
Crossref
Egbert-Jan van der Wouden, Jacob C. Thijs, Anton A. van Zwet & Jan H. Kleibeuker. (2001) Six-year follow-up after successful triple therapy for Helicobacter pylori infection in patients with peptic ulcer disease. European Journal of Gastroenterology & Hepatology 13:10, pages 1235-1239.
Crossref
Crossref
Rasool Sotudehmanesh, Reza Malekzadeh, Ali Fazel, Sadegh Massarrat, Behrooz Ziad‐Alizadeh & Mohammed Reza Eshraghian. (2001)
A randomized controlled comparison of three quadruple therapy regimens in a population with low
Helicobacter pylori
eradication rates
. Journal of Gastroenterology and Hepatology 16:3, pages 264-268.
Crossref
Crossref
A. Armuzzi, F. Cremonini, F. Bartolozzi, F. Canducci, M. Candelli, V. Ojetti, G. Cammarota, M. Anti, A. De Lorenzo, P. Pola, G. Gasbarrini & A. Gasbarrini. (2008)
The effect of oral administration of
Lactobacillus GG
on antibiotic‐associated gastrointestinal side‐effects during
Helicobacter pylori
eradication therapy
. Alimentary Pharmacology & Therapeutics 15:2, pages 163-169.
Crossref
Crossref
Frevel, Daake, Janisch, Kellner, Krezdorn, Tanneberger & Wack. (2000)
Eradication of
Helicobacter pylori
with pantoprazole and two antibiotics: a comparison of two short-term regimens
. Alimentary Pharmacology & Therapeutics 14:9, pages 1151-1157.
Crossref
Crossref
Michopoulos, Tsibouris, Bouzakis, Balta, Vougadiotis, Broutet & Kralios. (2001)
Randomized study comparing omeprazole with ranitidine as anti‐secretory agents combined in quadruple second‐line
Helicobacter pylori
eradication regimens
. Alimentary Pharmacology & Therapeutics 14:6, pages 737-744.
Crossref
Crossref
Melissa Rich, James M. Scheiman, William Tierney & A. Mark Fendrick. (2000) Is upper gastrointestinal radiography a cost-effective alternative to a Helicobacter pylori"Test and Treat" strategy for patients with suspected peptic ulcer disease?. The American Journal of Gastroenterology 95:3, pages 651-658.
Crossref
Crossref
Wong, Xiao, Hu, Qian, Huang, Li, Hu, Manan, Lesmana, Carpio, Perez, Fock, Kachintorn, Phornphutkul, Kullavanijaya, Ho & Lam. (2001)
Comparison of lansoprazole‐based triple and dual therapy for treatment of
Helicobacter pylori
‐related duodenal ulcer: an Asian multicentre double‐blind randomized placebo controlled study
. Alimentary Pharmacology & Therapeutics 14:2, pages 217-224.
Crossref
Crossref
D. K. Bhasin, B. C. Sharma, S. K. Sinha, P. Ray, K. Vaiphei & K. Singh. (1999) Helicobacter pylori Eradication: Comparison of Three Treatment Regimens in India. Journal of Clinical Gastroenterology 28:4, pages 348-351.
Crossref
Crossref
HOFFMAN, KATZ & CAVE. (1999)
Efficacy of a 1-week regimen of ranitidine bismuth citrate in combination with metronidazole and clarithromycin for
Helicobacter pylori
eradication
. Alimentary Pharmacology & Therapeutics 13:4, pages 503-506.
Crossref
Crossref
Marcia Samada Suárez, Juan González Cansino, Cira Velasco Ilizalde, Carlos Alfonso Sabatier & Juan Castillo Hernández. (1999) Three Treatment Schemes with Colloidal Bismuth Subcitrate (Q-ULCER) in Peptic Ulcer with Helicobacter pylori. Archives of Medical Research 30:1, pages 55-59.
Crossref
Crossref
B. D. Gold. 1999. Gastroduodenal Disease and Helicobacter pylori. Gastroduodenal Disease and Helicobacter pylori
71
102
.
Romuald J. Adamek, Boris Pfaffenbach & Christian Szymanski. (2001)
Cure of
H. pylori
Infection Using a 7‐Day Triple Therapy Combining Pantoprazole with Two Antibiotics
. Helicobacter 3:3, pages 206-211.
Crossref
Crossref
HIROSHI SAITA, MOTONOBU MURAKAMI, YOUJI TAKAHASHI, YASUNARI SOU, KAZUAKI KAITANI, KIYOSHI NISHIO & TORU KITA. (2008)
Factors influencing
Helicobacter pylori
eradication with 2 week combination therapy of lansoprazole and amoxycillin: Intragastric distribution of colonization and gastric mucosal atrophy
. Journal of Gastroenterology and Hepatology 13:7, pages 725-731.
Crossref
Crossref
F. Gomollón, J.A. Ducóns, L. Gimeno, J. Fuentes, S. García, J. Vera & M. Montoro. (2001) The Ideal Therapy Must Be Def ined in Each Geographical Area: Experience with a Quadruple Therapy in Spain. Helicobacter 3:2, pages 110-114.
Crossref
Crossref
Yoshinao Kobayashi, Masayoshi Doi, Hiroshi Nagata, Kazunori Sasaki, Toshiyuki Maruyama & Kazuhisa Murakami. (1998) A model for anti Helicobacter pylori Chemotherapy Using an Experimental Murine Infection with Helicobacter felis. Journal of Infection and Chemotherapy 4:4, pages 195-200.
Crossref
Crossref
R. Williamson & G. A. Pipkin. 1998. Helicobacter pylori. Helicobacter pylori
416
425
.
Francis K.L. Chan & Joseph J.Y. Sung. (1997) The Medical Care of Patients with Gastrointestinal Bleeding after Endoscopy. Gastrointestinal Endoscopy Clinics of North America 7:4, pages 671-686.
Crossref
Crossref
UWE BLECKER & BENJAMIN D. GOLD. (1997) Treatment of Helicobacter pylori infection: a review. The Pediatric Infectious Disease Journal 16:4, pages 391-399.
Crossref
Crossref
Allan D. Olson, A.Mark Fendrick, David Deutsch, Michael E. Chernew, Richard A. Hirth, Chirag Patel & Bernard S. Bloom. (1996) Evaluation of initial noninvasive therapy in pediatric patients presenting with suspected ulcer disease. Gastrointestinal Endoscopy 44:5, pages 554-561.
Crossref
Crossref
Wink A. de Boer, Ruud J. X. M. van Etten, J. Y. L. Lai, Peter M. Schneeberger, Branka A. M. van De Wouw & Willem M. M. Driessen. (2007) Effectiveness of Quadruple Therapy Using Lansoprazole, Instead of Omeprazole, in Curing Helicobacter pylori Infection. Helicobacter 1:3, pages 145-150.
Crossref
Crossref
Julie Parsonnet, Ryan A Harris, Howard M Hack & Douglas K Owens. (1996) Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials. The Lancet 348:9021, pages 150-154.
Crossref
Crossref
W. A. de Boer. (1996) How to Achieve a Near 100% Cure Rate for H. Pylori Infection in Peptic Ulcer Patients. Journal of Clinical Gastroenterology 22:4, pages 313-316.
Crossref
Crossref
Fiona J. Radcliff, Minhu Chen & Adrian Lee. (1996) Protective immunization against Helicobacter stimulates long-term immunity. Vaccine 14:8, pages 780-784.
Crossref
Crossref
C K Ching, K P Leung, R W Yung, S K Lam, B C Wong, K C Lai & C L Lai. (1996) Prevalence of metronidazole resistant Helicobacter pylori strains among Chinese peptic ulcer disease patients and normal controls in Hong Kong.. Gut 38:5, pages 675-678.
Crossref
Crossref
René W.M. van Der Hulst, Josbert J. Keller, Erik A.J. Rauws & Guido N.J. Tytgat. (2007) Treatment of Helicobacter pylori Infection: A Review of the World Literature. Helicobacter 1:1, pages 6-19.
Crossref
Crossref
Joseph J. Y. Sung, S. C. Sydney Chung, Thomas K. W. Ling, Roamy Suen, Vincent K. S. Leung, James Y. W. Lau, Augustine F. B. Cheng & Arthur K. C. Li. (1996) Dual therapy versus triple therapy forHelicobacter pylori-associated duodenal ulcers. Digestive Diseases and Sciences 41:3, pages 453-457.
Crossref
Crossref
K. E. L. McColl. (1996) Helicobacter pylori infection and its role in human disease ? an overview. Pharmacy World and Science 18:2, pages 49-55.
Crossref
Crossref
W. A. DE BOER, W. M. M. DRIESSEN & G. N. J. TYTGAT. (2007)
Only four days of quadruple therapy can effectively cure Helicobacter pylori
infection
. Alimentary Pharmacology & Therapeutics 9:6, pages 633-638.
Crossref
Crossref
T. G. REILLY, R. C. S. AYRES, V. POXON & R. P. WALT. (2007)
Helicobacter pylori
eradication in a clinical setting: success rates and the effect on the quality of life in peptic ulcer
. Alimentary Pharmacology & Therapeutics 9:5, pages 483-490.
Crossref
Crossref
Adam W. Harris & J.J. Misiewicz. (1995) 10 Eradication of Helicobacter pylori. Baillière's Clinical Gastroenterology 9:3, pages 583-613.
Crossref
Crossref
W.A. de Boer, W.M.M. Driessen, A.R. Jansz & G.N.J. Tytgat. (1995) Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection. The Lancet 345:8953, pages 817-820.
Crossref
Crossref
N. HUDSON, W. G. BRYDON, M. A. EASTWOOD, A. FERGUSON & K. R. PALMER. (2007)
Successful
Helicobacter pylori
eradication incorporating a one‐week antibiotic regimen
. Alimentary Pharmacology & Therapeutics 9:1, pages 47-50.
Crossref
Crossref
Larry L. Klein & S. Ken Tanaka. 1995.
151
158
.
A A van ZwetJ C ThijsW Schievink-de VriesJ SchiphuisJ A Snijder. (1994) In vitro studies on stability and development of metronidazole resistance in Helicobacter pylori. Antimicrobial Agents and Chemotherapy 38:2, pages 360-362.
Crossref
Crossref
J. C. THIJS, A. A. VAN ZWET, W. MOOLENAAR, J. A. J. OOM, H. DE KORTE & E. A. RUNHAAR. (2007) Short report: clarithromycin, an alternative to metronidazole in the triple therapy of Helicobacter pylori infection. Alimentary Pharmacology & Therapeutics 8:1, pages 131-134.
Crossref
Crossref